Free Newsletter

FierceVaccines is a weekly update on the vaccine industry, with a special focus on the innovations revolutionizing the development and production of vaccines. Join thousands of lab research professionals who get FierceVaccines via weekly email. Sign up today!

About | View Sample | Privacy

Hottest Products

Compare Top Solutions in:

Evaluate more than 400,000 products >>

Featured Jobs

Analyst, Procurement Operations Job
Celgene Corporation - Basking Ridge, NJ, US
Director, IT Global Operation Services, End-User Informatics Job
Celgene Corporation - Summit, NJ, US
Principal Scientist
Watson Pharmaceuticals - Fort Lauderdale, FL
Laboratory Facility Manager
International AIDS Vaccine Initiative - New York, NY
Clinical Research Coordinator
Lovelace Respiratory Research Institute - Albuquerque, NM

More Jobs >>

Events

Enforcement, Litigation and Compliance Conference
Dec. 6-7 — Washington, DC
Pharmacovigilance and Risk Management Strategies 2012
January 22-25, 2012 — Arlington, Virginia
New Paradigms to Fund & Move Biotech
January 11-12, 2012 — San Francisco, CA
CHI's Summit for Clinical Ops Executives (Scope)
February 7-9 — Miami

More Events >>

Related Tags >> OncoPep cancer vaccine

multiple myeloma News

Most Popular multiple myeloma Story

OncoPep vax aims to stop multiple myeloma before it starts

May 5, 2011 — 8:00am ET | By Maureen Martino

Massachussetts start-up OncoPep has raised $3.65 million to back development of a vaccine designed to prevent multiple myeloma before develops fully into the disease. Current treatment can extend Read more...

multiple myeloma Press Releases

Senesco Initiates Dosing in Phase 1b/2a Clinical Study of SNS01-T
Aeterna Zentaris to Report Third Quarter 2011 Financial and Operating Results on November 10, 2011
Keryx Biopharmaceuticals, Inc. to Host Conference Call on Third Quarter 2011 Financial Results
FDA Approves Addition of Sustained Overall Survival Advantage (5-year follow-up) to Label for VELCADE® in Patients w
For the Treatment of Multiple Myeloma Hematologist-Oncologists Consider the Performance of Velcade More Favorably than Rev

Latest Headlines

OncoPep vax aims to stop multiple myeloma before it starts
May 5, 2011

Paid Research Reports

Trends in mHealth and Telemedicine
The Global Aesthetic Dermatology Market Outlook
Future Directions in Regenerative Medicine
Pipeline Insight: Insulin Antidiabetics – Novel analogs show promise as alternative delivery methods prove less attractive
Pipeline Insight: Non-insulin Antidiabetics - Rise of the weight-reducers: Once-weekly GLP-1 agonists and novel SGLT-2 inhibitor
Forecast Insight: Antidiabetics - Diabetes market growth driven by epidemiological trends and rich pipeline

More Research Reports >>

THE FIERCEMARKETS NETWORK